Beyond Biotech - the podcast from Labiotech

2:55  Labiotech news 4:27  Mablink Bioscience On the podcast this week, we have a conversation about antibody-drug conjugates with Pejvack Motlagh, who was recently announced as the chief medical officer at Mablink Bioscience.  Mablink Bioscience  Mablink Bioscience is a biotechnology company developing the next generation of an emerging class of cancer drugs, antibody-drug conjugates (ADCs).  Mab...

2:38  Labiotech news 4:23  APSFA 20:59 University of Michigan June is Antiphospholipid Syndrome (APS) Awareness Month.  APS is a rare autoimmune disorder in which the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodies against them. There are two known forms. APS may occur in people with systemic lupus erythematosus, other autoimmu...

1:13  Labiotech news 3:09  Lund Spring Symposium 27:36 Sapient Sapient Sapient is an end-to-end biomarker discovery organization dedicated to accelerating the mapping of circulating chemistries in humans through rapid, large-scale small molecule biomarker profiling.  Its platform combines next-generation mass spectrometry technologies capable of assaying tens of thousands of small molecule biomark...

2:45  Labiotech news 4:58  Orgenesis 22:35 CellProthera 38:22 Terumo Blood and Cell Technologies 52:02 BioSenic The International Society for Cell & Gene Therapy (ISCT), the global society of more than 3,000 members dedicated to the translation of cell and gene therapies (CGT) into safe and effective treatments to improve patient lives, recently hosted the largest translation-focused event con...

1:24  Labiotech news 3:40  BC Platforms A conversation about precision medicine with Tero Silvola, CEO at BC Platforms. We also discuss the acquisition of 4Pharma. The acquisition expands BCP’s global service offering for accelerating the translation of innovations into clinical practice. In addition, 4Pharma customers will benefit from additional services in the field of RWD through the BC Platfo...

1:18  Labiotech news 3:37  BioInvent BioInvent International AB, a Swedish biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, recently announced positive phase 1a data on the oncolytic virus BT-001 for the...

1:33  Labiotech news 3:31  Daiichi Sankyo/AstraZeneca The companies Daiichi Sankyo and AstraZeneca have worked together for several years. This week’s podcast is sponsored by Daiichi Sankyo and AstraZeneca . On this week’s podcast, we have a conversation with Markus Kosch, the head of Oncology Europe and Canada for Daiichi Sankyo, and Greg Rossi, Senior Vice President, Oncology, Europe and Canada,...

4:26  Labiotech news 6:36  Medidata 21:43 Bill & Melinda Gates Research Institute This week’s podcast is sponsored by Jubilant Biosys . May 20 is International Clinical Trials Day. ECRIN,  the European Clinical Research Infrastructure Network, is a not-for-profit organization that supports the conduct of multinational clinical trials in Europe. Based in Paris, France, the organization launched...

This week’s podcast is sponsored by Quantoom . International MPS Awareness Day May is the big month when it comes to awareness - there are almost 100 awareness months, weeks, and days being marked. Some of these are well known conditions. Others, however, are less prominent. International MPS (mucopolysaccharidosis) Awareness Day takes place on May 15. According to the National MPS Society in the...

3:32  Labiotech news 5:33  Lupus interview This week’s podcast is sponsored by Lonza. May is Lupus Awareness Month, and to talk about lupus with us this week on the podcast are Katherine Tran, senior global market development & marketing manager of the proteomics division at SCIEX, and Allan Stensballe, associate professor, Department of Health Science and Technology and associate professor, T...

2:13  Labiotech news 5:17  bit.bio This week’s podcast is sponsored by Scientist.com . The mainstream news in the past couple of months has picked up on artificial intelligence (AI). Not so much its uses, more the potential for conflict and fears over AI developing too quickly, or ‘taking over humanity.’ Debates have sprung up around deepfakes, ChatGPT, and other AI technologies, and there are con...

2:05  Labiotech news 3:32  MEET2WIN 9:38 Lund Spring Symposium 19:31 Merck This week, we’re talking about the upcoming Lund Spring Symposium with Claes Wahlestedt, Leonard M. Miller professor and director of the Center for Therapeutic Innovation (CTI) and associate dean for therapeutic innovation at the University of Miami Miller School of Medicine;  about Meet2Win with Lucia Robert, CEO of MATWIN...

1:44  Labiotech news 3:27  Molecure This week, to coincide with World Sarcoidosis Day, April 13, we talk about sarcoidosis with Marcin Szumowski, CEO and president of the management board of Molecure.  World Sarcoidosis Day As part of Sarcoidosis Month, which is marked each April, World Sarcoidosis Day is on April 13. But what is sarcoidosis? The Foundation for Sarcoidosis Research explains that i...

3:13  Nectin Therapeutics 26:47 Immunome This episode of the podcast is an in-depth look at antibody drug conjugates (ADCs). Our guests are Dr Pini Tsukerman, chief scientific officer of Nectin Therapeutics, and Matthew Robinson, chief technology officer of Immunome. This episode of the podcast is sponsored by PHTA . Immunome Immunome’s Discovery Engine leverages the information stored in memory B...

2:57 Labiotech.eu news 4:17 PBD Biotech 14:52 AAHI 29:36 TB Alliance March 24 is World Tuberculosis Day. To mark the occasion, we have conversations with Christopher Fox, senior vice president, formulations, at the Access to Advanced Health Institute; TB Alliance CEO Mel Spigelman; and Jane Theaker, CEO of PBD Biotech. This episode of the podcast is sponsored by Samplix . World Tuberculosis Day Tu...

1:27 Labiotech.eu news 2:38 Allogenica 12:06 Helex 15:51 FreezeM 19:55 MediSieve The Hello Tomorrow Global Summit took place in Paris last week (March 8-10), and we feature interviews with four of the participants. Our guests this week are: FreezeM CEO and co-founder, Dr. Yuval Gilad; Allogenica CEO and co-founder Inna Menkova; George Frodsham, founder and CEO of MediSieve; and Poulami Chaudhuri,...

 1:19 Labiotech.eu news 2:32 Biomedical Research & Bio-Products 12:15 Model N 21:39 Institute of Clinical Medicine This week our guests are Marit Inngjerdingen from the Institute of Clinical Medicine in Norway; Kyle Forcier, senior director of life sciences product marketing at Model N; and Dr. Andreas Roetzer, head of R&D for vaccines at Biomedical Research & Bio-Products. The next br...

1:41 Labiotech.eu news 3:41 Cellular Origins 20:17 Bio-Europe Spring Two of the interviews on the podcast today are related to Bio-Europe Spring. There are conversations with Rosie Bernard, senior director, production and content strategy for EBD Group EU, with an overview of the event, and also Jordan Stillman, project manager, partnering services at EBD Group.  We also have a chat with Cellular...

0:58 Labiotech.eu news 2:37 Replay 23:45 Azafaros 39:39 GRO Biosciences As February 28 is Rare Disease Day, we have three guests on the podcast today all relevant to rare diseases. And they are Dan Mandell, CEO and co-founder of GRO Biosciences; Stefano Portolano, chief executive officer, Azafaros; and from Replay, Adrian Woolfson, executive chairman, president, and co-founder, and Lachlan MacKinn...

1:25 Labiotech.eu news 3:02 GPCR Therapeutics 22:16 eClinical Solutions 31:04 Orbsen Therapeutics This week, our guests are Katrina Rice, chief delivery officer, biometrics services at eClinical Solutions; Pina Cardarelli, president and CSO of GPCR Therapeutics; and Larry A Couture, CEO of Orbsen Therapeutics. GPCR Therapeutics launches multiple myeloma trial  GPCR Therapeutics, Inc., a drug disco...

1:10 Labiotech.eu news 2:50 Innovation Agency Lithuania 25:25 Astellas Pharma 34:37 4basebio This week, our guests are Romualda Stragienė, director at Innovation Agency Lithuania and Andrius Sliuzas, export key account manager of high tech industries at Innovation Agency Lithuania; 4basebio CEO Heikki Lanckriet; and Yoshitsugu Shitaka, chief scientific officer at Astellas. 4basebio 4basebio, a spi...

Sometimes, there’s an interview that’s just a bit long for the regular podcast. So we’re going to start an occasional series of podcasts where we look a bit more in depth at a condition, and what’s the current state of affairs in treatment. In this podcast, the first, we take a closer look at Alzheimer’s disease with a conversation about current drugs, clinical trials, and the pipeline. Our guest...

01:38 Labiotech.eu news 03:18 OncoHost 18:13 Enterome 41:04 TrakCel 55:51 Cancer Research Horizons/Turbine Our guests are Ofer Sharon, CEO of OncoHost; Matthew Lakelin, co-founder, TrakCel; Pierre Belichard, CEO of Enterome; and Tony Hickson, chief business officer for Cancer Research UK and Cancer Research Horizons and Daniel Veres, chief science officer and co-founder, Turbine. World Cancer Day...

01:22 Labiotech.eu news 03:03 Phacilitate/Advanced Therapies Week 14:15 Orgenesis 25:18 Terumo 31:47 VIVEBiotech 38:33 University of Birmingham Phacilitate’s Advanced Therapies Week took place last week in Miami Beach, Florida. This week, we speak with the organizers, as well as some of the companies in attendance. Our guests are Kim Barnes, EVP, Phacilitate; Kathie Schneider, director and global...

02:29 Labiotech.eu news 04:11 C2i Genomics 22:31 Advanced Therapies Congress 31:37 BioAlps 47:29 Bionter 54:06 JLL The guests on our podcast this week are: Jessica Robinson, project director, Advanced Therapies Congress, Terrapinn: Tobias Werk, CEO, Bionter; Asaf Zviran, CEO and co-founder of C2i Genomics; and Magali Bischof, secretary general of BioAlps. We also have our weekly commentary from Tr...